Drug Approval | August 18, 2023
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Subscribe To Our Newsletter & Stay Updated
